Genitourinary Oncology Primary Dreicer, Robert CRC: Drake, Jennifer 19-20484 PHAR B-701_U22 Stages: Any/all CT.GOV ID: NCT03123055   A Multi-Center, Single-Arm, Open-Label Phase 1b/2 Study of a Novel FGFR3 Inhibitor (B-701) Combined with Atezolizumab in Subjects with Locally Advanced or Metastatic Urothelial Carcinoma who have Progressed Following Platinum-based Chemotherapy Primary Dreicer, Robert CRC: Drake, Jennifer 19-21029 … Continue reading New Clinical Trials Opening in Hematology/Oncology